KJM The Korean Journal of MedicineKorean J Med 1738-9364 2289-0769 The Korean Journal of Medicine 10.3904/kjm.2018.93.2.87.e1 kjm-93-3-311 Erratum 2018 대한부정맥학회 비판막성 심방세동 환자의 뇌졸중 예방 지침 2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation LeeJung Myung 이정명 1 JoungBoyoung 정보영 2 ChaMyung-Jin 차명진 3 LeeJi Hyun 이지현 4 LimWoo Hyun 임우현 5 KimTae-Hoon 김태훈 2 ShinSeung Yong 신승용 6 UhmJae-Sun 엄재선 2 LimHong Euy 임홍의 7 KimJin-Bae 김진배 1 KimJun Soo 김준수 8 Division of Cardiology, Kyung Hee University Hospital, Seoul, Korea 경희대학교병원 순환기내과 Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea 연세대학교 세브란스병원 순환기내과 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea 서울대학교병원 순환기내과 Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea 서울대학교 분당병원 순환기내과 Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea 서울대학교 보라매병원 순환기내과 Department of Cardiology, Chung-Ang University Hospital, Seoul, Korea 중앙대학교병원 순환기내과 Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea 고려대학교 구로병원 순환기내과 Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 성균관대학교 삼성서울병원 순환기내과 1 6 2018 1 6 2018 93 3 311 312 Copyright © 2018 The Korean Association of Internal Medicine 2018 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Korean J Med 2018;93:87-109. https://doi.org/10.3904/kjm.2018.93.2.87

다음과 같이 본문 내 Table 5에 오류가 있어 수정합니다.

Table

Guidance for temporary interruption of NOAC before surgery

Dabigatran
 Apixaban, edoxaban, rivaroxaban
 Low-risk surgery High-risk surgery
Low-risk surgery High-risk surgery
Creatinine clearance >80 mL/min 24 hours 48 hours 24 hours 48 hours
Creatinine clearance 50-80 mL/min 36 hours 72 hours 24 hours 48 hours
Creatinine clearance 30-50 mL/min 48 hours 96 hours 24 hours 48 hours
Creatinine clearance 15-30 mL/min Not indicated Not indicated 36 hours 48 hours

NOAC, non-vitamin K antagonist oral anticoagulant.

Guidance for temporary interruption of NOAC before surgery

Dabigatran
 Apixaban, edoxaban, rivaroxaban
Low risk surgery High risk surgery Low risk surgery High risk surgery
Creatinine clearance >80 mL/min 24 hours 48 hours 24 hours 48 hours
Creatinine clearance 50-80 mL/min 36 hours 72 hours 24 hours 48 hours
Creatinine clearance 30-50 mL/min 48 hours 96 hours 24 hours 48 hours
Creatinine clearance 15-30 mL/min Not indicated Not indicated 36 hours 48 hours

NOAC, non-vitamin K antagonist oral anticoagulant.